Halopemide (C007B-184388)

Halopemide is a dopamine inhibitor and a PC-PLD2 (phospholipase D2) inhibitor. Halopemide may be used as a screen to identify inhibitors of human PLD2 using an in vitro biochemical assay. It is also inhibitory at benzodiazepine binding sites. Halopemide is an inhibitor of PC-PLD1 (PLD1).Application：Halopemide, a non-specific phospholipase D (PLD) antagonist, may be used with selective PLD antagonists (CAY10593, a PLD1 antagonist; CAY10594 or ML298, selective PLD2 antagonist) to help define the role and physiological effects regulated by phospholipase D enzymes. Halopemide may be used as the basis of the design and development of more selective PLD antagonists. Specification: 0.97 Molecular Formula: C21H22ClFN4O2 Molecular Weight: 416.88 PubChem CID: 65490 Isomeric SMILES: C1CN(CCC1N2C3=C(C=C(C=C3)Cl)NC2=O)CCNC(=O)C4=CC=C(C=C4)F Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/H334673-SCI_486c498654cd3c2ff3fc8d61ab404e80.pdf

UPC:

51333503

Condition:

New

Weight:

0.96 Ounces

HazmatClass:

No;ManufacturerName=Aladdin Scientific"

Quantity:

1

Unit of Measurement:

EA

WeightUOM:

LB

MPN:

H334673-25mg

CAS:

59831-65-1

Product Size:

25mg

Hazard Statement Codes:

H302

Precautionary Statement Codes:

P264:P270:P330:P301+P312:P501

Controlled Substances and Cyanide:

Yes